MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-TN-29-0005367
Innocure Pharma Private Limited
Innocure Pharma Private Limited - pharma in Tiruvannamalai, Tamil Nadu, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.35 Lakh
▲ 62% YoY
Net loss · FY 2025
₹2.54 Cr
Latest filing
EBITDA · FY 2025
-₹1.64 Cr
Latest filing
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹6.13 Cr
Issued & subscribed
Open charges
₹9 Cr
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
5
As per MCA filings
About Innocure Pharma Private Limited
Data last updated:
Innocure Pharma Private Limited is a private limited company based in Tiruvannamalai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U85300TN2019PTC131466.
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.13 Cr. It is led by directors including Venkatachalam Natarajan (Managing Director) and Unjanai Kaliannan Chitrarasan.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Tiruvannamalai, Tamil Nadu.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.35 Lakh, a growth of 62% compared to the previous year. For the same year it recorded a net loss of ₹2.54 Cr and EBITDA of -₹1.64 Cr.
As per MCA filings, the company has open charges of ₹9 Cr on record. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.12 Cr; the latest was in March 2022. Its 4 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 2 larger and 2 smaller; the largest is Valoris Healthcare Private Limited with revenue of ₹1.43 Lakh.
Innocure Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TN-29-0005367).
Company details
CIN U85300TN2019PTC131466
Registration Number 131466
Incorporation Date 05 September 2019
ROC Chennai
Listing Status Unlisted
Company Status Active
Date of Last AGM 29 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-TN-29-0005367
Key People
Venkatachalam Natarajan Managing Director Unjanai Kaliannan Chitrarasan Director Marimuthu Valarmathi Director Recognitions & Rankings of Innocure Pharma
Contact details
Innocure Pharma Private Limited's registered office is in Tiruvannamalai, Tamil Nadu. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No.C15 Sipcot Industrial Complex Cheyyar Phase II Mathur Village Vembak, Kam Taluk, Tiruvannamalai, Tamil Nadu, India – 631701
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Innocure Pharma Private Limited, buy the company report.
Comprehensive company report
Innocure Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Innocure Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Innocure Pharma Private Limited, buy the company report.
Financials of Innocure Pharma Private Limited
FY 2025 filings availableInnocure Pharma Private Limited reported revenue of ₹1.35 Lakh (up 62% YoY) for FY 2025.
Revenue · FY 2025
₹1.35 Lakh ▲ 62%
Net loss · FY 2025
₹2.54 Cr
EBITDA · FY 2025
-₹1.64 Cr
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 62%
EBITDA CAGR growth
1 year
▼ 24%
3 years · compounded
▼ 82%
5 years · compounded
▼ 323%
Revenue rose 62% in the latest year. EBITDA fell 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.64 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.54 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Innocure Pharma Private Limited, buy the company report.
Board of directors of Innocure Pharma Private Limited
Innocure Pharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Unjanai Kaliannan Chitrarasan | Director | 27 Mar 2025 | 1 Years 7 Months | Current |
| Marimuthu Valarmathi | Director | 05 Sep 2019 | 7 Years 1 Months | Current |
| Chinnusamy Balasubramanian | Director | 05 Sep 2019 | 7 Years 1 Months | Current |
| Kuppusamy Palanivelu Also directs: Gem Sree (Pondicherry)Chits Private Limited | Director | 05 Sep 2019 | 7 Years 1 Months | Current |
| Venkatachalam Natarajan | Managing Director | 05 Sep 2019 | 7 Years 1 Months | Current |
Peer comparison
Innocure Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Valoris Healthcare Private Limited | ₹1.43 Lakh (FY 2024) | Mulshi, Maharashtra, India | ||||
| Aardix Pharmaceuticals (OPC) Private Limited | ₹1.43 Lakh (FY 2022) | -4.0% | Kolkata, West Bengal, India | |||
| Innocure Pharma Private Limitedthis company | ₹1.35 Lakh (FY 2025) | -₹2.54 Cr | 62.0% | Tiruvannamalai, Tamil Nadu, India | ||
| Gayatri Pharmaceuticals Pvt Ltd | ₹1.35 Lakh (FY 2025) | -24.0% | Cuttack, Odisha, India | |||
| Athachi Wellness Solutions Private Limited | ₹1.34 Lakh (FY 2025) | 173.0% | Palakkad, Kerala, India |
To see the full peer comparison of Innocure Pharma Private Limited, buy the company report.
Auditor
Innocure Pharma Private Limited is audited by RITS AND ASSOCIATES for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RITS AND ASSOCIATES | FY 2022 | 010699S |
Shareholding
The shareholding of Innocure Pharma Private Limited is on record for 3 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Innocure Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹9 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Jul 2022 | 100596618 | Others | ₹9 Cr | Open |
Total charge records: 1 View all charges
Deals & funding
Innocure Pharma Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.12 Cr; the latest was in March 2022.
Total deals
2
Funding round
1
Secondary share transfer
1
Disclosed funding
₹6.12 Cr
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2022 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2021 | Funding round | ₹6.12 Cr | Investors: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Innocure Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Innocure Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Innocure Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Innocure Pharma Private Limited has 6 board changes on record since 2019: 5 appointments and 1 cessation. The latest: Unjanai Kaliannan Chitrarasan was appointed as Director on 27 Mar 2025.
AGM
Innocure Pharma Private Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records.
Filing
Innocure Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Chennai.
Appointed
Unjanai Kaliannan Chitrarasan was appointed as Director.
Charges
A charge with Others amounted to Rs. 9.00 Cr with Charge ID 100596618 was registered on 22 Jul 2022.
Ceased
Venkatachalam Natarajan ceased to be Director.
Appointed
Chinnusamy Balasubramanian was appointed as Director.
Appointed
Kuppusamy Palanivelu was appointed as Director.
Appointed
Marimuthu Valarmathi was appointed as Director.
Appointed
Venkatachalam Natarajan was appointed as Managing Director.
Incorporation
05 Sep 2019
Innocure Pharma Private Limited was registered on 05 Sep 2019 with Roc Chennai & aged 7 years 2 months as per MCA records.
Frequently asked questions
Innocure Pharma is an active private limited company based in Tiruvannamalai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 September 2019 (7+ years old) and is registered under CIN U85300TN2019PTC131466.
Innocure Pharma has 5 current directors:
- Venkatachalam Natarajan - Managing Director
- Unjanai Kaliannan Chitrarasan - Director
- Marimuthu Valarmathi - Director
- Chinnusamy Balasubramanian - Director
- Kuppusamy Palanivelu - Director
The latest financial statements of Innocure Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Innocure Pharma is U85300TN2019PTC131466. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Innocure Pharma was incorporated on 05 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chennai.
Innocure Pharma has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹6.12 Cr; the latest was in March 2022.
The peers of Innocure Pharma by revenue are Valoris Healthcare Private Limited, Aardix Pharmaceuticals (OPC) Private Limited, Gayatri Pharmaceuticals Pvt Ltd, Athachi Wellness Solutions Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Unjanai Kaliannan Chitrarasan was appointed as Director on 27 Mar 2025. Venkatachalam Natarajan ceased to be Director on 22 May 2020. Chinnusamy Balasubramanian was appointed as Director on 05 Sep 2019. Innocure Pharma has 6 board changes on record in total.
Yes, Innocure Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TN-29-0005367).
The registered office of Innocure Pharma is at Plot No.C15 Sipcot Industrial Complex Cheyyar Phase II Mathur Village Vembak, Kam Taluk, Tiruvannamalai, Tamil Nadu, India – 631701.
Innocure Pharma operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages